SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

US Patent Office Signals Patent for IRLAB Therapeutics’ IRL1117 Candidate

The US Patent Office has indicated that a patent for IRLAB Therapeutics’ drug candidate IRL1117 is forthcoming.

Related stories